Early mortality risk stratification after SARS-CoV-2 infection
Med Intensiva (Engl Ed)
.
2021 Nov;45(8):e40-e42.
doi: 10.1016/j.medine.2020.06.014.
Authors
D J Lundon
1
,
B D Kelly
2
,
S Nair
3
,
D M Bolton
2
,
N Kyprianou
3
,
P Wiklund
3
,
A Tewari
4
Affiliations
1
Department of Urology, Icahn School of Medicine, Mount Sinai Hospitals, New York, United States. Electronic address: Dara.Lundon@mountsinai.org.
2
Department of Urology, University of Melbourne, Austin Health, Melbourne, United States.
3
Department of Urology, Icahn School of Medicine, Mount Sinai Hospitals, New York, United States.
4
Department of Urology, Icahn School of Medicine, Mount Sinai Hospitals, New York, United States. Electronic address: Ash.Tewari@mountsinai.org.
PMID:
34717886
PMCID:
PMC8549443
DOI:
10.1016/j.medine.2020.06.014
No abstract available
Publication types
Case Reports
MeSH terms
COVID-19*
Humans
Risk Assessment
Risk Factors
SARS-CoV-2